<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02444260</url>
  </required_header>
  <id_info>
    <org_study_id>ECP342,12/13</org_study_id>
    <nct_id>NCT02444260</nct_id>
  </id_info>
  <brief_title>A Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation for Hernioplasty</brief_title>
  <official_title>Improving Patient Outcomes With Inguinal Hernioplasty - a Randomized Controlled Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of The West Indies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of The West Indies</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this RCT is to compare patient outcomes of inguinal hernioplasty under Local
      Anaesthesia alone versus Local Anaesthesia and Conscious Sedation

      Specific study objectives are to determine the effect of conscious sedation on:

      (i) patient satisfaction (ii) postoperative pain (iii) time to discharge (iv) intraoperative
      complications (v) postoperative functional status (vi) short-term postoperative complications
      (vii) long-term postoperative complications
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patient satisfaction as assessed with the Iowa Satisfaction with Anesthesia Scale</measure>
    <time_frame>1 year</time_frame>
    <description>Change in the Iowa Satisfaction with Anesthesia Scale from baseline (pre-discharge assessment)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency (total count) of postoperative complications using a questionaire</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative assessment of physical activity using Activities Assessment Scale</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discharge</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in postoperative pain score from baseline assessed with visual analog scale</measure>
    <time_frame>1 year</time_frame>
    <description>change in postoperative pain from baseline (pre-discharge assessment) assessed with visual analog scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Anesthesia, Local</condition>
  <condition>Conscious Sedation</condition>
  <arm_group>
    <arm_group_label>Intravenous Normal Saline</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Intravenous Normal Saline plus Lignocaine HCl (1%) - administered by wound infiltration to a maximum dose of 4.5mg/kg ; Bupivocaine HCl (0.25%) - administered by wound infiltration to a maximum dose of 2 mg/kg plus i</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lignocaine HCl (1%) - administered by wound infiltration to a maximum dose of 4.5mg/kg Bupivocaine HCl (0.25%) - administered by wound infiltration to a maximum dose of 2 mg/kg plus Midazolam - administered intravenously. 1 mg given stat. Titrated by 1 mg to a maximum dose of 10 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam will administered intravenously. 1 mg given stat. Titrated by 1 mg to a maximum dose of 10 mg. Additional sedation will be given to achieve and maintain a score of 2-3 on the Ramsay sedation scale during the procedure, up to the maximum dose of 10mg.</description>
    <arm_group_label>Midazolam</arm_group_label>
    <other_name>Dormicum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Normal Saline</intervention_name>
    <description>Intravenous normal saline will be infused by non-blinded anaesthetist</description>
    <arm_group_label>Intravenous Normal Saline</arm_group_label>
    <other_name>0.9% sodium chloride solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivocaine</intervention_name>
    <description>Bupivcaine 0.25% solution administered by wound infiltration to a maximum dose of 2 mg/kg</description>
    <arm_group_label>Intravenous Normal Saline</arm_group_label>
    <arm_group_label>Midazolam</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lignocaine HCl</intervention_name>
    <description>Lignocaine !% solution administered by wound infiltration to a maximum dose of 4.5mg/kg</description>
    <arm_group_label>Intravenous Normal Saline</arm_group_label>
    <arm_group_label>Midazolam</arm_group_label>
    <other_name>xylocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reducible inguinal hernia

        Exclusion Criteria:

          -  Renal, hepatic, respiratory, cardiovascular, neurologic or psychiatric disease

          -  Body mass index &lt; 18.5 kg/m2 or &gt; 30 kg/m2

          -  Recurrent inguinal hernias

          -  Bilateral inguinal hernias

          -  Large inguinoscrotal hernias

          -  Incarcerated hernia

          -  Allergies to local anaesthetic and sedative agents

          -  Pregnancy

          -  Lactation

          -  Chronic pain syndromes

          -  Anxiety disorders

          -  Marijuana use

          -  Long term use of opioid or sedative agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre Leake, DM</last_name>
    <email>Pierre-Anthony Leake &lt;paeleake@yahoo.com&gt;</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marvin Reid, PhD</last_name>
    <email>marvin.reid@uwimona.edu.jm</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of the West Indies, mona</name>
      <address>
        <city>Kingston</city>
        <state>Please Select</state>
        <country>Jamaica</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Leake, DM</last_name>
      <email>Pierre-Anthony Leake &lt;paeleake@yahoo.com&gt;</email>
    </contact>
  </location>
  <location_countries>
    <country>Jamaica</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2015</study_first_submitted>
  <study_first_submitted_qc>May 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2015</study_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inguinal Hernia,</keyword>
  <keyword>Local Anesthesia</keyword>
  <keyword>Randomized Clinical trial</keyword>
  <keyword>HERNIOPLASTY</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

